Headline News about Revance Therapeutics![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022
September 22, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Needham Maintains Buy Rating for Revance Therapeutics: Here's What You Need To Know
September 09, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|